Mairi Whiston, Early Diagnosis Senior Projects Officer at Myeloma UK, outlines a new tool to help laboratories with myeloma testing practices.
Every day counts when it comes to myeloma, an incurable blood cancer. With a median diagnostic interval of 163 days in the UK, patients face unnecessary delays that impact their survival rates and quality of life. Laboratories play a vital role in the diagnostic pathway and communication among healthcare professionals (HCPs). However, recent
UK surveys show variations in myeloma testing practices and a desire from laboratories for guidance on best practice.
To address this, my colleagues and I at the charity Myeloma UK collaborated with NHS HCPs to develop the Monoclonal Gammopathy Lab Tool. In this article, I will outline the key recommendations and explore how the tool can enhance lab practice to improve the timely and accurate diagnosis of myeloma.
Click here to read the full article.
Image credit | Science-Photolibrary
